Baijin Life Science Holdings Ltd

01466

Company Profile

  • Business description

    Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company produces health products that are affordable for the general public. The business segments of the company are Life Science segment which includes cellular technology-based services, provide including cellular drugs R&D, large molecule drugs R&D, clinical research services and R&D and sales on self-owned skincare brand, and Fine Jewelry segment that focuses on the procurement, processing, design, production and wholesale distribution of pearls and fine jewelry products.

  • Contact

    66 Gloucester Road
    Office B, 9/F Pico Tower
    Wanchai
    Hong Kong
    HKG

    T: +852 36112188

    http://www.affluent-partners.com

  • Sector

    Consumer Cyclical

    Stock type

    Cyclical

  • Industry

    Luxury Goods

    Fiscal Year End

    31 March 2025

    Employees

    84

Stocks News & Analysis

video

Do you qualify as 'rich'?

Morningstar's Sim Mody speaks with Mark LaMonica about the varying definitions of rich. 
stocks

Solid sales from ASX healthcare leader

Solid device sales with shares moderately undervalued.
stocks

Megatrend Investing: ASX players to capitalise on the clean energy transition

Find out how you can benefit from global megatrends.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,683.4050.000.58%
CAC 407,887.0819.32-0.24%
DAX 4021,520.3314.630.07%
Dow JONES (US)44,556.04134.130.30%
FTSE 1008,594.4723.700.28%
HKSE20,597.09192.87-0.93%
NASDAQ19,654.02262.061.35%
Nikkei 22538,831.4833.110.09%
NZX 50 Index12,844.5960.45-0.47%
S&P 5006,037.880.000.00%
S&P/ASX 2008,416.9042.900.51%
SSE Composite Index3,229.4921.11-0.65%

Market Movers